Return to study ST001073 main page

MB Sample ID: SA072459

Local Sample ID:HA_22
Subject ID:SU001117
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:Tcf/LacZ mice
Age Or Age Range:6-8 weeks
Gender:Male and female
Animal Inclusion Criteria:The Tcf/LacZ strain was previously backcrossed onto the C3H background C3H background, and confirmed by PCR to lack the rd1 mutation

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR001131
Treatment Summary:Mice of either sex were randomly selected to receive intravitreal injection of recombinant 20ng Wnt3a ligand group or saline control group (saline was injected with equivalent volume as recombinant 20ng Wnt3a ligand). A small diabetic needle was used to make an incision in the superior posterior area of the conjunctiva-sclera border of the left eye. After which, either recombinant 20ngWnt3a ligand or saline was injected intravitreally using a 1.5 cm 33-gauge Hamilton needle (Hamilton Company, Reno, NV). The injection needle was angled to avoid hitting the lens. The surface membrane of the left eye was cut around the conjunctiva-sclera border. Dumont #5 forceps were inserted between the membrane and the globe to move the surrounding tissues while searching for the optic nerve. Once the optic nerve was located, the forceps’ teeth surrounded the nerve 1 mm from the globe and crushed the nerve for 5 seconds. The crush is successful if there is very minimal or no damage to the surrounding blood supply. Affected left eyes were treated with topical erythromycin ointment and 1mg/ml of Buprenorphine-SR lab was injected subcutaneously. Animal Anesthesia: ketamine/xylazine cocktail intraperitoneally, eyes were locally anesthetized with 0.5% proparacaine hydrochloride.Any mouse with excessive bleeding around the eye was excluded from the study. Mouse’s overall health and left eye’s health were monitored daily from day 1 post crush until day 7 post crush. Animal Endpoint Clinical Signs: Mice portraying lethargy 24 hours after surgery or eye infection to the affected eye days after surgery were excluded from the study.
Treatment:optic nerve crush, intravitreal injection
Treatment Compound:Wnt3a or saline
Treatment Route:intravitreal injection
Treatment Dosevolume:20 ng of Wnt3a or equal volume of saline
Treatment Doseduration:single injection
Animal Anesthesia:See summary
Animal Endp Euthanasia:CO2 + decapitation
Animal Endp Tissue Coll List:retina, optic nerve
Animal Endp Clinical Signs:See summary
  logo